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Abstract: 
 The hamster estrous cycle lasts four days and is considered to be a physiological model 
for angiogenesis.  Angiogenesis is the formation of new capillaries from preexisting vessels, and 
it occurs extensively during corpus luteum formation in the estrous cycle.  Von Willebrand 
Factor (vWF) is a glycoprotein that is secreted uniquely in endothelial cells and megakaryocytes.  
It is frequently used as an endothelial cell marker and it is able to detect vessels within tissues 
when it is used in immunohistochemical staining techniques.  This study explores von 
Willebrand Factor expression within Golden Hamster ovarian tissue.  In particular, this study 
uses cage control and antiorthostatic cage suspension tissue.  Antiorthostatic cage suspension is a 
model developed to mimic and study the physiological effects caused by microgravity, such as 
that experienced in space flight.  It is hypothesized that simulated microgravity caused by 
antiorthostatic cage suspension would result in lower levels of vasculature and expression of 
vWF within ovarian tissue.  Due to financial considerations, conclusive data was not obtained 
due to a lack of statistics.  However, our study indicates that vasculature and vWF expression 
may be increased in antiorthostatic cage suspension tissue.   
Keywords:  von Willebrand Factor, vascular endothelial cells, immunohistochemistry, 
antiorthostatic, microgravity 
 
Introduction: 
 The ovarian cycle of mammals has been extensively researched in the laboratory due to 
its repetitious nature as it relates to the cellular proliferation and differentiation that coincides 
with the follicular development, corpus luteum formation, and corpus luteum regression 
4 
 
(Kaczmarek et al., 2005).  These changes that occur within the ovary during the ovarian cycle 
require changes in the vascularization.  This study focused on these vascularization changes 
within the hamster estrous cycle by visualizing an endothelial cell marker, von Willebrand 
Factor, that exists within the vascular endothelial cells of Golden Hamster (Mesocricetus 
auratus) ovarian tissue.  We also conducted a comparative study by looking at the expression in 
vWF among cage control tissue and tissue that has been subjected to antiorthostatic suspension. 
The Estrous Cycle: 
 The hamster estrous cycle lasts approximately four days and is comprised of two phases: 
the follicular phase and the luteal phase (Forsman and McCormack, 1992).  The follicular phase 
begins with a primordial follicle within the ovary.  A follicle is defined as a group of cells that 
surrounds an oocyte (Lawrence, 1995).  Follicles are formed by specialized epithelial cells 
known as granulosa cells, and multiple follicles can be present during any given estrous cycle.  A 
primordial follicle is comprised of a single layer of granulosa cells surrounding a primary oocyte.  
The follicle begins to develop in response to the gonadotrophin Follicle Stimulating Hormone 
(FSH) release by the anterior pituitary.  As the follicle develops, the epithelial cells multiply and 
serve as a wall around the oocyte.  Once this “wall” becomes six cells thick, the immediately 
surrounding stromal cells differentiate and become what is known as the theca.  The follicle is 
now a secondary follicle that consists of both an outer thecal layer, which functions as the main 
source of estrogen, and an inner granulosa layer, which is the main source of progesterone 
(Perry, 1972).  It is important to note that the theca of the continuously growing and maturing 
follicle is extremely vascular.  The inner granulosa layer, however, is avascular (Forsman and 
McCormack, 1992; Kaczmarek, et al., 2005; Perry, 1972; Reynolds, et al., 1992).  Separating the 
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two layers is a basal membrane called the membrane propria which serves as a barrier so that 
there is no vascular penetration into the granulosa layer until after ovulation (Perry, 1972).   
 As the follicle continues to develop, an antrum begins to form.  This occurs when a rift 
appears within the granulosa layer initially forming a fluid-filled slit.  As the follicle continues to 
grow and expand, the antrum enlarges and eventually accounts for most of the follicle’s volume 
(Perry, 1972).  At this time, the theca layer is now fully developed and it consists of two separate 
capillary networks, one in the theca interna and one in the theca externa (Kaczmarek, et al., 
2005).  The theca externa is formed as a result of the outer stromal cells being compressed.  The 
internal layer of the theca is the theca interna, which is made up of an envelope of condensed 
connective tissue known as the theca folliculi (FreeDictionary.com).  Together, the theca interna 
and theca externa appear structurally as a “hollow ball” (Forsman and McCormack, 1992).   
 Up until ovulation, the follicle is secreting the hormone estrogen which causes the female 
to be in a sexually receptive state known as estrous.  Estrous typically occurs right before 
ovulation.  Near the end of estrous, Luteinizing Hormone (LH), another gonadotrophin from the 
anterior pituitary, causes ovulation.  At the time of ovulation, the follicle ruptures and the oocyte 
is expelled (Perry, 1972).   
 After ovulation, the Luteal phase immediately begins.  During this phase a temporary 
organ, the corpus luteum, forms from the remains of the ruptured follicle.  It is during this time 
the blood flow to this tissue is at its highest (Forsman and McCormack, 1992).  The granulosa 
cells begin to hypertrophy at a rapid rate and they luteinize and begin to secrete progesterone.  
Progesterone is the hormone that prepares the uterus to accept and nourish the developing 
embryo if fertilization were to occur.  The blood vessels within the theca can now penetrate the 
membrane propria, and the newly formed luteal tissue begins to become highly vascularized 
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(Perry, 1972; Kaczmarek, et al., 2005).  The new vascularization starts from the vessels of the 
theca externa and the vessels begin to grow in an inward direction.   This leads to a very complex 
network of blood vessels so that the initial “hollow ball” of the theca becomes a mature corpus 
luteum that is structurally similar to a “solid ball” (Forsman and McCormack, 1992). The mature 
corpus luteum has the greatest blood flow of any tissue in the entire body (Kaczmarek, et al., 
2005).  During this time, the microvascular endothelial cells are the most abundant and 
continuously proliferating cells within the developing corpus luteum (Kaczmarek, et al., 2005), 
and approximately 50% of the cells within the mature corpus luteum are these endothelial cells 
(Reynolds, et al., 1992).  If no fertilization and subsequently no pregnancy occurs, the corpus 
luteum regresses rapidly and progesterone secretion ceases. At this time, FSH is again secreted 
from the anterior pituitary and follicular maturation can begin again.  It is because of the 
hamster’s rapid growth and degeneration of its corpus luteum that makes the golden hamster 
particularly useful in laboratory studies as it is considered to be a physiological model for 
angiogenesis (Forsman and McCormack, 1992).   
Angiogenesis: 
 The formation of the vascular networks that comprise the corpus luteum and allows for 
the increase in blood flow in the ovary results from a process known as angiogenesis.  
Angiogenesis is the formation of new capillaries by sprouting from pre-existing small blood 
vessels (Lawrence, 1995).  Angiogenesis is important because it allows for hormone producing 
cells to obtain oxygen and other vital nutrients, in addition to allowing hormone transfer and 
substrate delivery to the target tissues (Kaczmarek, et al., 2005).  This is important because the 
corpus luteum is an endocrine organ that secretes its hormones directly into the bloodstream.  
Angiogenesis is usually considered to be involved with pathological conditions such as tumor 
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growth, wound healing, retinopathies, and inflammatory processes.  However, angiogenesis is a 
physiological and normal process in the female reproductive organs, such as the ovary 
(Augustin, et al., 1995).   
Angiogenesis begins with capillary proliferation, which consists of three different stages: 
1) fragmentations occur within the basal lamina of the existing blood vessel, 2) endothelial cells 
of the existing blood vessel migrate towards the angiogenic stimulus, and finally 3) the 
endothelial cells proliferate.  Completion of the new blood vessel arises once a new capillary 
basal lamina is formed and the new capillaries are differentiated into arterioles and venules 
(Kaczmarek et al., 2005; Reynolds, et al., 1992).  The fact that endothelial cells play such a 
crucial role in angiogenesis provides further rationale for why there are such a high percentage 
(50%) of them present within the corpus luteum.  Often times angiogenic factors can be localized 
within these endothelial cells.   
 When it comes to angiogenic factors, there are two different types to be considered: 1) 
factors that act directly on vascular endothelial cells and 2) factors that act indirectly by means of 
mobilizing host cells to release endothelial growth factors (Folkman and Klagsbrun, 1987).  Two 
very potent direct angiogenic factors are Vascular Endothelial Growth Factor (VEGF) and 
Fibroblast Growth Factor-2 (FGF-2).  These factors not only stimulate angiogenesis, but they 
also control the expression of the endothelial cell marker von Willebrand Factor (vWF).  When 
the angiogenic factors VEGF and FGF-2 are present, they up regulate the vWF mRNA and 
protein levels within the endothelial cells.  Von Willebrand Factor mRNA is derived from 
vascular endothelial cells and megakaryocytes and is a particularly useful endothelial cell 
marker.  It can be used to detect early signs of angiogenesis because it detects the initial 
activation of the endothelium (Zanetta, et al., 2000).   
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Von Willebrand Factor:  
Von Willebrand Factor is a glycoprotein with a multimeric structure.  Von Willebrand 
Factor can have a mass of anywhere between 500 and 10,000 kilodaltons (kDa).  Electron 
microscopy has shown it to be either a filamentous structure or a loosely coiled molecule.  
Within the mulitmeric structure of vWF, there are a series of oligomers that can contain a wide 
range of subunits.  The number of subunits possible ranges from between two and one hundred.  
Within these subunits, there is a relatively high carbohydrate content with approximately 10-19% 
of the total mass of a mature subunit being carbohydrates.  The most significant characteristic 
about vWF’s structural composition is that it has a high cysteine content.  This is essential for 
vWF because it links all of the subunits into a high-order structure.  This complex molecular 
structure of vWF allows for the potential of numerous contact sites with the platelets and 
subendothelial structures (Ruggeri and Ware, 1993).   
 Von Willebrand Factor is produced solely by the endothelial cells and megakaryocytes 
(Pusztaszeri, et al., 2006; Ruggeri and Ware, 1993; Wagner, et al., 1982; Zanetta, et al., 2000).  
The vWF is found within the endothelial cells and subendothelial matrix of the vessel wall, and 
is found in the blood in both the plasma and the platelets (Ruggeri and Ware, 1993).  It has also 
been identified in the vascular lumen (Pusztaseri, et al., 2006).  The vWF protein has several 
functions.  It is required for the normal arrest of bleeding that occurs during hemostasis, or tissue 
injury, by aiding in the binding of platelets to the subendothelium.  It also serves as the carrier 
for coagulation factor VIII within the circulating blood, in which the two proteins form a factor 
VIII/vWF complex.  Von Willebrand Factor also is crucial for the adhesion of the endothelial 
cells to the vessel basal lamina, in addition to serving as a bridge between the components of the 
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vessel wall and specific receptors on the platelet surface (Pusztaseri, et al., 2006; Ruggeri and 
Ware, 1993; Zanetta, et al., 2000). 
 While vWF is expressed uniquely in the endothelial cells and megakaryocytes, it is 
important to note that not all endothelial cells express von Willebrand Factor.  In addition to this, 
expression levels of vWF can differ significantly among the endothelial cells of different murine 
tissues.   Expression levels of vWF can also differ when it comes to venous and arterial 
endothelial cells of the same tissue type.  In fact, vWF has been found to be expressed in higher 
concentrations on the venous side, rather than the arterial side, of the capillary circulation 
(Zanetta, et al., 2000).   In order, veins have the strongest expression of vWF, followed by the 
arteries, arterioles, capillaries, and venules (Pusztaszei, et al., 2006). 
 The synthesis of von Willebrand Factor is controlled at the transcriptional level within 
the endothelial cells and megakaryocytes (Zanetta, et al., 2000).  After synthesis, vWF is stored 
in specific organelles: Weibel-Palade bodies for endothelial cells and the α-granule for the 
megakaryocytes and platelets (Pusztaszei, et al., 2006; Ruggeri and Ware, 1993; Wagner, et al., 
1982; Zanetta et al., 2000).  Weibel-Palade bodies originate from the Golgi Apparatus and are 
rod shaped organelles that derive uniquely in endothelial cells (Ruggeri and Ware, 1993; 
Wagner, et al., 1982). Weibel-Palade bodies contain another protein known as β-selectin.  β-
selectin is a cell adhesion molecule that is postulated to be involved in the interactions of 
leukocytes with the endothelial cells and platelets (Ruggeri and Ware, 1993). 
 There are two different pathways that regulate the secretion of vWF.  The first is the 
constitutive pathway that is directly linked to synthesis.  The other is a regulated pathway in 
which there is storage in the appropriate organelles and then there is release after stimulation.  
Von Willebrand Factor within megakaryocytes generally is expressed via the regulated pathway.  
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Endothelial cells, on the other hand, typically secrete vWF through the constitutive pathway.  
However, when agonists such as histamines, estrogens, thrombins and fibrins are present, the 
endothelial cells secrete the stored vWF in a regulated fashion (Ruggeri and Ware, 1993).   
Immunohistochemistry:  
Because vWF is an endothelial cell marker, it is commonly used to identify vessels 
within tissue sections because vessels are lined with endothelial cells.  This is done with 
immunohistochemical staining techniques.  Immunohistochemistry was first developed in 1941 
by Coons, et al. when they identified a technique for detecting cellular antigens in tissue sections.  
Since then, immunohistochemistry has served as a fundamental tool in anatomic pathology for 
research and diagnostic purposes (Cregger, et al., 2006; Ramos-Vara, 2005).  The fundamental 
concept behind immunohistochemistry is the visualization of antigens within tissue sections by 
means of specific antibodies binding to the antigens, followed by a colored histochemical 
reaction. 
 An antigen is characterized as any substance capable of specific binding to an antibody or 
a T-cell receptor (Lawrence, 1995).  Antigens are proteins, and as such, can have many different 
isoforms (structures).  However, a common problem among antigens located within fixated 
tissue is that the fixation can modify the tertiary structure of the antigen.  This is problematic as 
it may make the antigens undetectable by antibodies that should have specificity for them.  
Therefore, antigen retrieval methods are often employed (Ramos-Vara, 2005). 
 Antigen retrieval methods are important because they unmask antigens hidden by 
formalin cross-links in fixation.  As such, antigen retrieval can 1) expand the range of antibodies 
able to be used in immunohistochemistry, 2) reduce false-negative staining results in over-fixed 
tissues, and 3) allow for greater diagnostic accuracy (Shi et al., 1991).  Antigen retrieval methods 
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vary, with enzyme digestion and heat-based methods being the most popular (Ramos-Vara, 
2005).  Shi et al. developed the microwave-heating method in 1991.  This method heated slides 
to up to 100oC, preferably in two separate five minute cycles in the microwave, with a one 
minute interval in between.  New methods of heat-induced antigen retrieval came into 
popularity, with methods such as autoclaving, pressure cooking, steam heating, and the water 
bath.  It has been found, however, that the method of heating is of no importance; the high 
temperature achieved during heating, however, is the most important factor when it comes to 
antigen retrieval (Shi, et al., 1997).   
 Once the antigens are accessible, the specific antibodies can bind to them.  Antibodies, 
also known as immunoglobulins (Ig), are Y shaped with two identical light chains and two 
identical heavy chains, with both the light and heavy chains being of the same type.  The light 
chains consist of 2 different regions.  The first region is the C terminal half, which is constant 
(CL).  The second region is the N-terminal half, which has abundant sequence variations (VL).  
The antigen binding portion of the Ig molecule is the Fab region which contains both types of 
variable regions: VH (heavy chains) and VL (light chains).  The number of stable VH and VL 
interactions are increased by the presence of the CL domains.  This contributes to the overall 
diversity of the antibody molecule expressed by the animal (Kindt, et al., 2007).  The tail of the 
Y is made up of the Fc portion, which determines the biological functions of the antibody and 
allows it to bind to other antibodies.  However, the Fc region can also allow the binding of the 
antibody to non-immune cells, such as inflammatory cells, creating background staining due to 
non-immune adherence of antibodies to tissue sections (Ramos-Vara, 2005).   
 The antigen binding site of the antibody is known as the paratope.  The epitopes are the 
regions of the antigen that bind to antibodies.  Epitopes can be anywhere from 5-21 amino acids 
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in length.  The most important aspect of an epitope is its tertiary structure, or the way in which 
the peptide chains of the protein are folded.  This is because it is the tertiary structure that 
dictates how a protein will interact, and hence, which antibody it will bind to.  The paratope and 
the epitope interact by means of non covalent bonds, particularly Van Der Waals forces and 
electrostatic interactions.  The more bonding interactions that occur, the greater the affinity 
between the antigen and antibody (Ramos-Vara, 2005). 
 In order to make specific antibodies, an animal such as a mouse, rabbit, or goat, is 
immunized with the particular peptide/antigen of interest (Cregger, et al., 2006; Ramos-Vara, 
2005).  The animal then produces antibodies that specifically recognize and bind to that antigen.  
There are two different types of antibodies: polyclonal and monoclonal.  Polyclonal antibodies 
can be made in a variety of different animals.  They have a higher affinity, wide reactivity, and 
lower specificity.  Therefore, they are more likely to identify a variety of isoforms of the target 
antigen.  Because of this, the potential for false-positive results is greater.  Monoclonal 
antibodies, on the other hand, have a very high specificity.  They are created mostly in mice, but 
can be generated from rabbits as well (Ramos-Vara, 2005).   
 For use in immunohistochemistry, antibodies are commonly made as either primary or 
secondary antibodies.  Primary antibodies target a specific antigen and are usually unlabelled.  
Secondary antibodies are made to bind to the primary antibody.  These secondary antibodies are 
labeled with a biotin carrier protein.   A third reagent is then applied, streptavidin horseradish 
peroxidase (HRP), which binds and tags the biotinylated secondary antibody.  Diamino-
Benzidine (DAB) is a common HRP substrate that binds to this tag and generates a brown-
colored staining product.  This enables the antigens within the tissue to be viewed with the aid of 
light microscopy. 
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Antiorthostatic Simulated Microgravity: 
 The immunohistochemical study we conducted involved visualizing von Willebrand 
Factor within the vascular endothelial cells of hamster ovaries.  We visualized vWF in two 
different types of tissue: cage control and antiorthostatic suspension tissue.  Antiorthostatic 
suspension is a technique that involves orienting the animal in an approximate 30o head down 
tilt.  It was developed in response to the necessity of studying the physiological systems that 
change in a microgravity environment (Chapes, et al., 1993).  According to spaceflight.nasa.gov, 
microgravity is a state in which gravity is reduced to almost negligible levels, such as during 
space flight.  Microgravity in space flight has been shown to have dramatic effects on the 
physiological systems of the body (Chapes, et al., 1999).  In order to study these effects, it was 
necessary to create a model that parallels the changes that occur in the microgravity of space, 
without the drawbacks of spaceflight studies.  These drawbacks include: scheduling, 
experimental duration, ease of experimental manipulation, the ability to repeat and extend 
experiments, and of course, financial drawbacks (Morey-Holton, et al., 2002).   
 The antiorthostatic suspension model that has been widely accepted is the hindlimb 
unloading model, which has been approved by the NASA ARC Animal Care and Use 
Committee.  The development of this hindlimb unloading model began as a cooperation between 
the United States and the USSR in 1975 on the Cosmos Spaceflight Mission (Morey-Holton, et 
al., 2002).  In 1979, Morey-Holton described the simulation of space flight with the hindlimb 
unloading model that involved keeping rats at a 30o head-down tilt.  This was accomplished by 
completely unloading the hindlimbs of the rat.  The angle measurement was important because it 
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allowed for 50% of the animal’s bodyweight to be dispersed to its forelimbs, and it only 
unloaded the lumbar and not the cervical vertebrae (Morey-Holton, et al., 2002).   
 The hindlimb unloading model simulates weightlessness, and as such, mimics the many 
physiological changes due to microgravity.  These changes include cephalad fluid shifts, 
movement of the abdominal organs toward the thorax, muscle atrophy, decrease in bone muscle 
density, and in addition, the hydrostatic gradient is minimized within the cardiovascular system.  
In addition to this, changes in capillarization, oxidative capacity, and immunological responses 
also occur in response to unloading (Chapes, et al., 1993; Morey-Holton, et al., 2002).  While the 
hindlimb unloading model does provided similar physiological changes to the microgravity 
actually experienced in space, no model is perfect as one cannot completely escape the effects of 
gravity on Earth’s surface.  In addition to this, the reentry and readaptation to gravity that occurs 
during spaceflight is also not accounted for during the unloading model (Morey-Holton, et al., 
2002).  However, until these obstacles are overcome by a better simulated microgravity model, 
antiorthostatic suspension in the hindlimb unloading model continues to be used and accepted.   
Spaceflight microgravity and simulated microgravity induced by the hindlimb unloading 
model have similar physiological changes in the muscle and bone.  Other similar changes 
occurred in the heart, pulmonary, intestine, immune, endocrine, and reproductive functions as 
well (Morey-Holton and Globus, 2002).  This preliminary study deals with the changes in the 
reproductive functions due to antiorthostatic suspension.  The cephalad fluid shifts that occur in 
response to antiorthostatic suspension could be responsible for the changes because the fluids 
move out of the caudal portion of the animal and settle in the cephalic region of the body.  This 
in turn exerts a greater amount of pressure on the vasculature of that region, thereby causing 
changes in that vasculature (Pattison, et al., 1991).  The vasculature in the reproductive organs is 
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hypothesized to change in response to simulated microgravity as well.  This is because the fluid 
and blood shifts away from the lower abdomen, and therefore, the reproductive organs 
themselves.  If blood circulation to the abdominal organs, including the ovary, has been altered, 
the vasculature of the antiorthostatic suspension hamster ovaries is hypothesized to be reduced 
compared to the vasculature of the cage control hamsters.  The expression of vWF is also 
hypothesized to be decreased in the antiorthostatic suspension hamster ovaries.  
Materials and Methods: 
Immunohistochemistry is a procedure that detects specific protein molecules within tissue 
cells.  This study focused on the ovarian tissue of the Golden Hamster (Mesocricetus auratus).  
All of the procedures in the study that were related to animal use were approved by the 
University Committee on Animal Care at East Tennessee State University in Johnson City, 
Tennessee.  In addition, all procedures conformed to the US National Institutes of Health’s 
Guide for Care and Use of Laboratory Animals (1996).  The female hamsters were continuously 
kept on a 14:10 hour light:dark cycle at temperatures of 21-23oC.  Each hamster used 
experienced 3 consecutive four day estrous cycles prior to the beginning of the experiment.  Day 
1 of each cycle was determined by a vaginal discharge that was observed between 0700 and 0900 
hours.  The hamsters were then checked daily until the discharge was again observed.  Hamsters 
were then checked on each Day 1 of their 4-day estrous cycle that followed until the suspension 
or perfusion took place.  Once the hamsters were suspended, they could no longer be checked for 
their Day 1 start of their estrous cycle as that would interfere with their suspension.  Therefore, 
the control hamsters were not checked as well.   
Twenty Golden Hamsters were used for the antiorthostatic suspension study in two 
separate groups of ten.  One group consisted of control hamsters that were kept in conventional 
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cages.  The other group of ten hamsters was placed in suspension cages at 1700 hour on Day 4 of 
their estrous cycle.  The suspension cages consisted of wire mesh bottom cages equipped with a 
metal rod running length-wise along the top of the cage.  The wire mesh bottom was used as 
opposed to traditional cage bedding in order to reduce the possibility of the bedding being piled 
up, thereby reducing the suspension angle of the hamsters.  The hamsters were suspended 
according to a modified technique used by Wronski, Morey-Holton (Armstrong et al., 1993).  In 
the normal suspension technique, animals (typically rats or mice) are suspended by their tails.  
This is problematic because hamsters do not have much of a tail.  Therefore, modifications of the 
technique described by Armstrong et al. were necessary.  These modifications involved a lot of 
strategic taping of the hamsters.  The hind feet and ankles were wrapped in medical tape in order 
to ensure the foot was maintained at a 90o angle to the leg.  Tape was then wrapped around the 
lower abdomen, hips, and thighs to fix the thighs in a continual and slight forward/flexed 
position.  Plaster casting strips were placed over the tape around the lower abdomen to prevent 
the hamsters from gnawing through the tape.  Once the plaster hardened, the suspension 
mechanism was taped to the dorsal surface of the cast (Figure 1).  The suspension mechanism 
consisted of a small metal ring around the suspension bar above the cage, a 360o swivel, and 
extended paperclips to adjust the length of the apparatus in order to keep the hamsters at a 
constant approximate head-down tilt angle of 30o.  In order to reduce friction of the metal ring on 
the bar, scotch tape was wrapped around the surface of the suspension bar.  This made it easier 
for the ring to slide, allowing free range of movement with the hamsters’ front limbs while their 
rear limbs remained elevated (New and Forsman, 2001).   
All of the hamsters used in the study were in the weight range of 101.9g-136.1g.  The 
cage antiorthostatic microgravitivity hamsters were left suspended for approximately one week 
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before euthenization.  Euthenization of the ten cage control and the ten cage suspended hamsters 
occurred at the following day and times in their estrous cycle: 0400, 1000, and 2200 of Day 1, 
1000 and 2200 of Day 2, 1000 and 2200 of Day 3, and 1000, 1600, and 2200 of Day 4.  These 
days and times of their estrous cycle were approximated from the hamsters’ three consecutive 
estrous cycles prior to suspension.  The hamsters were subjected to CO2 euthanasia, the 
abdominal cavities were incised, and the ovaries were removed.  The ovaries were then 
immediately immersed in a 1% formalin fixative. 
The tissue used was fixed and paraffin embedded and prepared by Jeff Stirman, a student 
working in the lab of Allan Forsman.  The fixation involved a 12 hour emersion of the tissue at 
4oC in 1% paraformaldehyde, followed by another 12 hours at 4oC in 4% paraformaldehyde.  
The paraformaldehyde soaks were then followed by three different one-hour emersions in a 
sucrose solution comprised of 0.1M PO4, 2% sucrose, and 50mM NH4Cl.  Two separate one-
hour incubations in 0.1 M PO4 and 50mM NH4Cl followed.  This was then followed by a series 
of thirty minute washes in 30% EtOH, 50% EtOH, and 70% EtOH.   
 Next, the tissue was dehydrated in order for it to be embedded in paraffin, starting with 
thirty-minute emersions each in 80%, 85%, 90%, 95%, and two in 100% EtOH.  These EtOH 
emersions were then followed by a thirty minute bath of a 50/50 100% EtOH/Hemo-De solution 
and a thirty minute emersion in 100% Hemo-De.  The tissue was then gradually subjected to an 
embedding paraffin called paraplast by submersing the tissue in a 50/50 solution of Hemo-
De/paraplast for thirty minutes at 58oC.   The paraplast was then further infiltrated into the tissue 
by immersing the tissue in two separate containers of pure paraplast at 58oC for one hour each.  
Finally, the paraffin embedded tissue was placed in embedding molds, covered with melted 
paraffin, and allowed to cool completely. 
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 The embedded tissue was then sectioned using a Microm HM325 microtome.  Due to 
time restraints, this study used tissue from ten of the twenty different hamster specimens: 5 cage 
control hamster tissues, and 5 cage suspension hamster tissues.  The tissue for both cage control 
and cage suspension tissues were from Day 1 (PM), Day 2 (PM), Day 3 (AM), Day 3 (PM), and 
Day 4 (PM).  The tissue blocks were cut in a manner that shaved the excess paraffin off so that 
only a small amount remained around the tissue in a trapezoid shape.  The tissue block was then 
positioned in the microtome and the microtome was set to cut the tissue in 4 micrometer 
sections.  Once the tissue was cut, the tissue was then floated out in a warm floatation water bath 
filled with distilled water with two drops of glycerin.  The tissue was then mounted on acid-
washed microscope slides and placed on a slide warmer to dry overnight. 
 The acid-washed slides were prepared using an acid wash of 10% HCl concentration.  
This was prepared by adding 60mL of 100% HCl to 540mL 70% EtOH.  This acid wash was 
done in order to ensure the slides were completely clean.  This is important for use in 
immunohistochemistry because the cleaner the slides, the better the adhesion of the tissue 
sections.  This helps prevent the tissue sections floating off of the slides during the 
immunohistochemical staining procedure.  The slides were dipped in the acid wash basin for 5 
minutes.  This was followed by two subsequent emersions in distilled water for a few minutes 
each.  The slides were then put into an oven at 58oC overnight to ensure the slides were 
completely dry before storage or use.   
 A Blood Vessel Staining Kit Peroxidase System was purchased from Millipore (Catalog 
No. ECM590) to be used for immunohistochemical analysis.  First, the reagents provided within 
the kit needed to be prepared for use.  The 20x Rinse Buffer was diluted to a 1x Rinse Buffer 
using distilled water.  The chromagen reagent that was provided in the kit was 3,3’ 
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diaminobenzidine tetrachloride (DAB).  The chromagen reagent was prepared so that there was a 
1:25 ratio of the supplied DAB Chromagen A and DAB Chromagen B.  Also, a citrate buffer 
was prepared using 2.1 citrate monohydrate and 1000mL distilled water, and adjusted until the 
solution was at a pH of 6.0.   
 Once all of the reagents were prepared, immunohistochemistry could begin.  First, it was 
important to properly label each slide so that slides do not get mixed up as to which antibodies 
are being applied and which slides are controls.  The procedure then began with the 
deparaffinizing and rehydration of the tissue.  The tissue-mounted slides were submersed in 
Coplin jars filled with various solutions.  To deparaffinize the tissue, the slides were submersed 
in two separate jars of pure xylene each for five minutes.  This was followed by two submersions 
in 100% EtOH for two minutes each.  The slides were then submersed in jars of 95%, 80%, and 
70% EtOH for two minutes each.  Finally, the slides were immersed in jars of distilled water and 
1x Rinse Buffer for five minutes each.   
 A microwave antigen retrieval method was used according to histochem.net in order to 
retrieve any antigens which were masked by the tissue fixation.  A Coplin jar containing the 
deparaffinized slides was filled with prepared citrate buffer and microwaved at medium-low 
power for 5 minutes. Additional citrate buffer was added to replace any evaporated losses and 
the jar/slides microwaved for an additional 5 minutes at medium-low power.  Citrate Buffer was 
again added and the slides cooled in solution to room temperature.  At this time, the slides were 
blotted dry and a Secure-Seal hybridization chamber gasket (Molecular Probes. Lot # 38006A) 
was applied to each slide and 3% hydrogen peroxide was added until the tissue specimen was 
covered.  The hydrogen peroxide aides in opening the binding sites.  The hydrogen peroxide was 
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left on for 10-30 minutes.  The tissue sections were then rinsed with 1x Rinse Buffer two times 
for five minutes each.   
 The staining procedure follows the tissue pretreatment, and it is critical to note that at 
absolutely no time during the staining procedure should the tissue sections be allowed to dry out.  
First, a blocking step is performed in order to avoid any non-specific binding of the primary 
antibody.  The kit provided a ready-to-use blocking reagent, and this was applied to each tissue 
specimen until it was completely covered and was left on for 15-30 minutes.  The slides were 
then rinsed with 1x Rinse Buffer for at least fifteen seconds.  The rabbit anti-vWF polyclonal 
primary antibody provided in the kit was diluted to a 1:400 dilution.  To prepare this solution, 
two drops of the blocking reagent were added to 5 mL of 1x Phosphate Buffer Saline (PBS).  
Then, 997.5 µL of this blocking reagent/PBS solution was transferred to a small vial and 2.5 µL 
of the rabbit anti-von Willebrand Factor polyclonal primary antibody was added to achieve the 
1:400 dilution.  The 1:400 diluted antibody (or a negative control of PBS) was then applied to 
each slide for 2 hours, making sure that at no time did the antibody solution dry out within the 
hybridization chamber.  Following the incubation time, the slides were rinsed three times for five 
minutes each in 1x Rinse Buffer. 
 The next step was to apply the provided goat anti-rabbit secondary antibody specific for 
the primary antibody or a PBS negative control.  The antibody solution was applied so that it 
completely covered the tissue specimen on the slide.  The slides were monitored so that they 
would not dry out during the fifteen minute incubation time.  The tissue was subsequently rinsed 
three times with 1x Rinse Buffer for five minutes each.  Following treatment with secondary 
antibody (or PBS control) the tissues were treated with Streptavidin-Horseradish Peroxidase.   
Streptavidin-Horseradish Peroxidase amplifies a weak signal by allowing 2 labeled and tagged 
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secondary antibodies to bind to each primary antibody, and then 2 Streptavidin-Horseradish 
Peroxidase molecules can bind to each labeled secondary antibody, for a total of 4 Streptavidin-
Horseradish Peroxidases.  This is done with high sensitivity and low background staining, which 
allows a target molecule, in this case vWF, to be detected.  The Streptavidin-HRP was applied 
for fifteen minutes in an enclosed container, followed by three consecutive washes of 1xRinse 
Buffer for five minutes each. 
 In order to actually see the targeted protein molecules (von Willebrand Factor), a stain 
must be applied.  To accomplish this, a chromagen reagent was used.  The previously prepared 
chromagen reagent was applied to the slides for ten minutes.  Immediately following incubation 
with the chromagen reagent, the Secure-Seal hybridization chamber gaskets were removed and 
the slides were placed in a Coplin jar filled with tap water.  The jar was then placed under a 
running tap faucet for 5-10 minutes.  The last step of the immunohistochemistry staining 
technique involved doing a dehydration process.  The dehydration involves a graduated series of 
alcohol baths in order to drive out any residual water from the tissue, in addition to removing 
excess DAB reagent.  This involved putting the slides in 70%, 80%, 95%, and two 100% EtOH 
Coplin jars for three minutes each.  This was followed by clearing the tissue in xylene with two 
consecutive submersions in 100% xylene, each for five minutes.  Clearing in xylene makes the 
sections hydrophobic so that a coverslip can be applied.  Also, the xylene has a similar refractive 
index as the proteins in the tissue which minimizes the light diffraction and promotes nearly 
optically perfect images (Gill, 2010).  Finally, 1-2 drops of Permount, a xylene-based mounting 
medium, was applied to the tissue-mounted slides and a coverslip was slowly lowered so that the 
Permount completely spread.  The slides were then allowed to dry overnight before storing in 
slide boxes.   
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 Once the immunohistochemistry procedure was complete, it was now possible to analyze 
the slides under a microscope. This study used a Fisher Scientific Micromaster Microscope in 
order to view the slides and photograph them with the aid of Westover Scientific Micron 
Imaging Software.  Blood vessel and Follicular counts were done manually with the use of this 
technology. 
 
Results: 
Mouse vs. Hamster: 
 The Blood Vessel Staining Kit Peroxidase System (Millipore #ECM590) was designed 
for use with mouse and human tissue.  Dr. Allan Forsman’s laboratory had available both actual 
spaceflight mouse tissue and simulated microgravity hamster tissue.  Initially, we started with 
practice ground control mouse tissue from the spaceflight project.  Several mouse tissues were 
subjected to the immunohistochemistry technique including ovary, uterus, kidney, brain, muscle, 
heart, and spinal cord.  No staining resulted in any of the various tissue types.  Figure 2 shows no 
positive staining within the mouse ovary.  Figure 3 shows no positive staining within mouse 
muscle tissue.  We then decided to test if the kit showed cross reactivity with hamster tissue.  
Hamster ovarian tissue was subjected to immunohistochemistry alongside mouse ovarian tissue.  
Figure 4 shows that positive staining did occur within the hamster tissue.  Therefore, hamster 
ovarian tissue was used throughout the rest of the study. 
Cage Control Hamsters: 
 The section through the ovary from the hamster euthanized at 2200 on Day 1 of the 
estrous cycle (H14-LO-B) had 19 follicles of varying size.  Three follicles were unilaminar (one 
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layer of granulosa cells surrounding the oocyte).  Three follicles were bilaminar, three follicles 
were trilaminar, and ten follicles were multilaminar.  Within the tissue sections, there were 13 
blood vessels (Table 1).  Figure 5 shows that most of the positive staining for vWF occurs in the 
blood vessels in between several multilaminar follicles.  In addition to this, there is a lot of small 
excess staining in endothelial cells that are potential new blood vessels.    
 The section through the ovary from the hamster euthanized at 2200 on Day 2 of the 
estrous cycle (H17-RO-B) had 1 corpus luteum and multiple follicles.  The follicles consisted of 
23 mulitlaminar follicles, 2 trilaminar follicles, 1 bilaminar follicle, and 3 unilaminar follicles.  
There were approximately 94 blood vessels within the tissue section (Table 2).  Most of the 
vasculature was surrounding the multilaminar follicles, especially in regions where the follicles 
appear to share neighboring vessels.  Staining for vWF occurred heavily in the vasculature of the 
corpus luteum, in addition to many small and flat vessels surrounding the multilaminar follicles.  
Figure 6 shows the staining that occurred within the small vessels in between multiple 
multilaminar follicles.   
 The section through the ovary from the hamster euthanized at 1000 on Day 3 of the 
estrous cycle (H11-RO-B) contained 11 follicles.  Of these follicles, 5 were unilaminar, 1 was 
bilaminar and 5 were mulitlaminar.  There were also 2 corpora lutea within the ovarian tissue 
section.  There were 22 blood vessels counted within the ovary, not including the numerous 
amounts of tiny vessels seen within the corpora lutea (Table 3).  The vessels that stained positive 
for vWF were mostly oval shaped, with some being flat and skinny vessels.  These vessels were 
in the regions surrounding the multilaminar follicles.  There was also staining within the 
vasculature of the corpora lutea.  
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 The section through the ovary from the hamster euthanized at 2200 on Day 3 of the 
estrous cycle (H13-RO-B) had 2 corpora lutea that contained high levels of vasculature and high 
levels of positive staining for vWF in the vascular endothelial cells.  There were numerous 
follicles, including 2 unilaminar follicles, 4 bilaminar follicles, 1 trilaminar follicle, and 5 
multilaminar follicles.  There were 31 blood vessels within the ovarian tissue section (Table 4).  
The majority of the vessels that stained for vWF were small and oval and located in regions of 
neighboring follicles. 
 The section through the ovary from the hamster euthanized at 2200 on Day 4 of the 
estrous cycle (H19-LO-B) contained 14 follicles. Of these, there were 3 unilaminar follicles, 4 
trilaminar follicles, and 7 multilaminar follicles.  There were also 2 large corpora lutea present.  
When it came to the blood vessel counts, there were 92 blood vessels, in addition to the 
numerous vessels in the corpora lutea (Table 5).  The vast majority of the positive staining for 
vWF occurred in the corpora lutea and in regions surrounding the follicles, particularly the 
multilaminar follicles.   
Antiorthostatic Suspension Hamsters: 
 The section through the ovary from the antiorthostatic cage suspended hamster 
euthanized at 2200 on Day 1 of the estrous cycle (H9-LO-B) contained 5 follicles.  Of these 
follicles, 2 were bilaminar, 2 were trilaminar, and 3 were multilaminar.  No corpus luteum was 
present.  There were 15 blood vessels that were minute in size with minimal staining for vWF in 
the vascular endothelial cells surrounding them (Table 6).  The vessels that did have positive 
staining were surrounding one of the larger multilaminar follicles.   
 The section through the ovary from the antiorthostatic cage suspended hamster 
euthanized at 2200 on Day 2 of the estrous cycle (H6-LO-B) contained 25 follicles.  These 
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follicles consisted of 7 unilaminar, 5 bilaminar, 3 trilaminar, and 10 multilaminar.  In addition to 
the numerous follicles present within the ovarian tissue section, there were also 2 corpora lutea 
(not shown in Figure 7).  The corpora lutea contained extensive vasculature, and within this 
vasculature, there was extensive staining of vWF.  There were 63 blood vessels throughout the 
tissue section, not including the vasculature in the corpora lutea (Table 7).  The vasculature was 
predominately located around the larger follicles, especially the multilaminar follicles.  There 
were not a lot of blood vessels in the regions of unilameter follicles (Figure 7). 
The section through the ovary from the antiorthostatic cage suspended hamster 
euthanized at 1000 on Day 3 of the estrous cycle (H1-RO-B) contained the most vasculature of 
the various tissue sections.  It contained 114 vessels among 10 multilaminar follicles.  In 
addition, there were 3 corpora lutea present that also contained extensive vasculature not 
included in the previous blood vessel count (Table 8).  Most of the vessels resided in the middle 
of the tissue section where they were surrounded by several large follicles.  The staining of the 
vascular endothelial cells occurred extensively in the corpora lutea (Figure 8).  There was also a 
great deal of positive staining in small oval vessels surrounding multilaminar follicles (Figure 9).  
 The section through the ovary from the antiorthostatic cage suspended hamster 
euthanized at 2200 on Day 3 of the estrous cycle (H2-LO-A) contained 3 unilaminar follicles, 1 
bilaminar follicle, 3 trilaminar follicles, and 9 multilaminar follicles.  There were 24 vessels 
within the tissue section (Table 9).  The blood vessels that stained positively for vWF were small 
and oval in shape (Figure 10). 
 The section through the ovary from the antiorthostatic cage suspended hamster 
euthanized at 2200 on Day 4 of the estrous cycle (H3-LO-A) contained 2 corpora lutea and 18 
follicles.  The makeup of these follicles is as follows: 5 unilaminar, 2 bilaminar, 3 trilaminar, and 
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8 multilaminar.   There were 91 blood vessels within the tissue section, in addition to the 
elaborate vasculature in the corpora lutea (Table 10).  The blood vessels that stained positively 
were mostly located between 4 multilaminar follicles and a neighboring corpus luteum, which 
also had extensive staining in its vasculature.  The positively stained blood vessels in this tissue 
section were unique in that they were much larger in size than any of the previous tissue sections.   
 
Discussion: 
One of the problems with immunohistochemical staining is that it lacks standardization 
when it comes to tissue fixation conditions, specimen pretreatment, reagents used, detection 
methods employed, and the interpretation of results.  The interpretation of results is difficult 
because statistics used for immunohistochemistry are varied and currently require expensive 
commercially available automated analysis systems specifically designed for use with 
immunohistochemistry (Cregger et al., 2006).  We did not have such analysis systems available 
to us; therefore this study was forced to take a qualitative approach to data analysis as opposed to 
a quantitative one.   
 Twenty sections of the cage control hamster ovarian tissue were viewed, and there were 
an average of 17 follicles per section.  The average composition of follicles is as follows: 3.2 
unilaminar, 1.8 bilaminar, 2 trilaminar, and 10 multilaminar follicles per section.  There were an 
average of 1.4 corpora lutea per section and 50.4 blood vessels, not including the extensive 
vasculature within each corpus luteum.  Most of the vessels were surrounding multilaminar 
follicles, with an average of 3-6 vessels per multilaminar follicle.  The vascular endothelial cells 
that stained positively for vWF were typically small, oval vessels in regions neighboring 
multilaminar follicles.   
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 The antiorthostatic cage suspended hamster ovarian tissue sections had a slightly lower 
average follicle number than the cage control tissue with an average of 15.2 follicles per section, 
with 32 sections viewed.  These were comprised of an average of 3 unilaminar, 2 bilaminar, 2.2 
trilaminar, and 8 multilaminar follicles per section.  There was an average of 1.4 corpora lutea 
per section, the same average as the cage control tissue.  The average number of blood vessels 
was higher in the anitorthostatic cage suspended tissue with 61.4 vessels per section, not 
including the vasculature of the corpora lutea.  This is the opposite of what was initially 
hypothesized that the vasculature would decrease in the antiorthostatic cage suspended hamsters.  
The staining of vascular endothelial cells for vWF also appeared to be increased in the 
antiorthostatic cage suspended hamsters.  This is to be expected since there was an increase in 
the vasculature in the antiorthostatic cage suspended tissue.  However, this goes against the 
findings of Pattison, et al., 1991 that showed that the blood and fluid flow away from the 
abdominal organs to the cephalic region of the body.  This shift in blood flow presumably causes 
lower blood pressure in the abdominal vessels, such as the vasculature within the ovary. 
The type and location of vessels that stained seemed to be consistent with the cage 
control hamsters in that most were small, oval vessels near multilaminar follicles.  Because of 
their small oval shape, it would be nice to be able to say that they are flat veins, as described by 
Forsman and McCormack, 1993.  This would coincide with the research that vWF expression is 
higher on the venous side of capillary circulation (Pusztaszeri, et al., 2006; Zanetta, et al., 2000).  
Unfortunately, this cannot be stated definitively as it is difficult to distinguish between the 
different types of vessels within the tissue sections in this study.  The vessels within the ovary 
are present in every direction, and we are unable to determine which angle the blade of the 
microtome sliced through each vessel.  Therefore, we are unable to determine whether the 
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vessels seen in our tissue sections were cross sections, longitudinal sections, or oblique sections 
through the vessels.  Therefore, further studies would need to be done to determine the types of 
vessels that stain for vWF with the highest percentage.   
If more time and money were available for this study, more tissue-mounted slides would 
be subjected to the immunohistochemistry techniques.  This would allow for more data to 
eliminate any statistical outliers and significant differences due to small sample size.  Also, with 
more data, time, and money, statistics could be run with the proper software in order to have a 
quantitative study.  Therefore, future studies need to be done in order to obtain statistically 
relevant data.   
This study did determine significant information that will be useful for future studies on 
this subject.  The Blood Vessel Staining Kit Peroxidase System purchased from Millipore was 
created for use on mouse and human tissue; other tissue types were not specified.  Our study 
shows that the antibodies and staining kit did not work on mouse tissue, but instead worked on 
hamster tissue.  Therefore, we will be notifying the Millipore company with this information to 
benefit other researchers. 
Xylene is used extensively in the immunohistochemical process.  Xylene has numerous 
hazardous effects as it is flammable, a strong skin irritant, and should not be inhaled or ingested.  
CitriSolv is a xylene substitute that is much safer to handle and work with.  The final 
immunohistochemistry run of this study added three additional slides, 2 standard and 1 control, 
in order to test if the use of CitriSolv had any effect on the staining of the tissue sections.  The 
results show that CitriSolv does not have any impact on the staining technique.  Therefore, it is 
advised that future experimentation on this subject use the safer CitriSolv over xylene.   
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The use of hematoxylin, a counterstain that stains the nuclei of cells blue while retaining 
the brown color of positive stains, is optional in the immunohistochemistry technique.  When this 
counterstain was applied in this study, differentiation between the blue staining and brown 
staining was difficult.  It could be observed with difficulty with the use of the eyepiece on the 
microscope; however, the camera would not identify the color distinction as it was not of the 
highest quality available.  
In conclusion, while this preliminary study was a qualitative one with inconclusive 
results, much has been learned that can aid researchers in future experimentation on the 
expression of von Willebrand Factor within the vasculature in hamster ovaries.  It has been 
observed that vWF has been expressed greatly in small, oval vessels in regions of multilaminar 
follicles.  It has been observed in this study that vasculature and thereby vWF expression 
increased in antiorthostatic cage suspension hamster ovarian tissue sections.  This goes against 
the hypothesis that vasculature would decrease in antiorthostatic cage suspension hamsters due to 
research that has shown that blood and fluid flow away from the abdominal organs into the 
cephalic region of the body.  Angiogenesis normally occurs as a physiological process within the 
ovary; however, angiogenesis is also involved in pathological conditions such as wound healing 
and inflammatory processes (Augustin, et al., 1995).  Perhaps an explanation for our reverse 
findings is that antiorthostatic cage suspension could have caused a pathological condition, 
therefore stimulating angiogenesis and leading to an increase in vasculature compared to cage 
control hamster ovarian tissue.  Another probable explanation for these reverse findings is that 
whether the hamster is subjected to antiorthostatic simulated microgravity or not, it still requires 
the same amount of blood since the mature corpus luteum has the greatest blood supply in the 
body (Kaczmarek, et al., 2005).  Because it is presumable that the cephalic fluid shifts causes 
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decreased blood pressure in the ovarian and other abdominal vasculature, perhaps more 
angiogenesis occurs to compensate for the decreased blood flow, since the organ still requires the 
copious amount of blood.   Further experimentation is necessary to gather more data with 
statistics to further test these explanations and these findings.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
 
References: 
 
Armstrong, J. W., K. A. Nelson, S. J. Simske, M.W. Luttges, J. J. Iandolo, S. K. Chapes.  
“Skeletal unloading causes organ-specific changes in immune cell responses.”  J Appl Physiol 
1993 Dec; 75(6):2734-2739 
 
Augustin, H. G., K. Braun, I. Telemenakis, U. Modlich, W. Kuhn.  “Phenotypic Characterization 
of endothelial cells in a physiological model of blood vessel growth and regression.”  Am J 
Pathol 1995; 147:339-351. 
 
Chapes, S. K., S. J. Simske, A. D. Forsman, T. A. Bateman, R. J. Zimmerman.  “Effects of space 
flight and IGF-1 on immune function.”  Adv space Res 1999; 23(12):1955-1964. 
 
Chapes, S. K., A. M. Mastro, G. Sonnenfeld, W. D. Berry.  “Antiorthostatic suspension as a 
model for the effects of spaceflight on the immune system.”  J Leukoc Biol 1993; 54:227-235. 
 
Coons, A. H., R. N. Jones.  “Immunological properties of an antibody containing a fluorescent 
group.”  Proc Soc Exp Biol Med 1941; 47:200-202. 
 
Cregger, M., A. J. Berger, D. L. Rimm.  “Immunohistochemistry and quantitative analysis of 
protein expression.”  Arch Pathol Lab Med 2006 Jul; 130:1026-1030. 
 
Folkman, J., M. Klagsbrun.  “Angiogenic factors.”  Science 1987 Jan; 235(4787):442-447. 
 
Forsman, A. D., J. T. McCormack.  “Microcorrosion casts of hamster luteal and follicular 
vasculature throughout the estrous cycle.”  The Anatomical Record 1992; 233:515-520. 
 
Free Dictionary.  Theca Folliculi. TheFreeDictionary.com.   
http://medical-dictionary.thefreedictionary.com/theca+folliculi.  Accessed 10/27/10. 
 
Gill, G.W.  “H&E Staining.”  Connection 2010;14:137-143.   
 
 
 
 
32 
 
Histochem.  Antigen Retrieval.  Histochem.net. 2006. 
http://www.histochem.net/histochemistry%20protocol%20antigen%20retrieval.htm  
Accessed 10/13/10.   
 
Kaczmarek, M. M., D. Schams, A. J. Ziecik.  “Role of vascular endothelial growth factor in 
ovarian physiology-an overview.”  Reproductive Bio 2005 Jun; 5(2):111-136. 
 
Kindt, T. J., R. A. Goldsby, B. A. Osborne, J. Kuby.  Kuby Immunology.6th ed. New York: W. 
H. Freeman and Company, 2007.  
 
Lawrence, E.  Henderson’s Dictionary of Biological Terms. 11th ed. New York: John Wiley & 
Sons, Inc., 1995. 
 
Morey-Holton, E. R., R. K. Globus.  “Hindlimb unloading rodent model: technical aspects.”  J 
Appl Physiol 2002; 92:1367-1377. 
 
NASA. References: Glossaries. Spaceflight.nasa.gov. 1999. 
http://spaceflight.nasa.gov/history/shuttle-mir/references/glossaries/science/sc-gloss-g_m.htm.  
Accessed 11/27/10. 
 
New, A., A. D. Forsman.  “The effects of simulated microgravitivity on the angiogenesis of the 
corpus luteum of the golden hamster.” Senior Honors Thesis 2001. 
 
Pattison, A., T. Pattison, J. Schechter.  “Pars distalis vasculature: discovery shuttle STS-29 rats 
compared to ground-based antiorthostatic rats.”  The Anatomical Record 1991; 231:347-350. 
 
Perry, John.  The Ovarian Cycle of Mammals. New York:Hafner Publishing Company, 1972. 
 
Pusztaszeri, M. P., W. Seelentag, F. T. Bosman.  “Immunohistochemical expression of 
endothelial markers CD31, CD34, von Willebrand Factor, and Fli-1 in normal human tissues.”  J 
Histochem Cytochem 2006; 54(4):385-395.  
 
Ramos-Vara, J. A.  “Technical aspects of immunohistochemistry.”  Vet Pathol 2005; 42:405-
425. 
 
33 
 
Reynolds, L. P., S. D. Killilea, D. A. Redmer.  “Angiogenesis in the female reproductive 
system.”  FASEB J 1992; 6:886-892. 
 
Ruggeri, Z. M., J. Ware.  “von Willebrand Factor.” FASEB J 1993; 7:308-316. 
 
Shi, S-R., R. J. Cote, C. R. Taylor.  “Antigen retrieval immunohistochemistry: past, present, and 
future.”  J Histochem Cytochem 1997; 45(3):327-343. 
 
Shi, S-R., M. E. Key, K. L. Kalra.  “Antigen retrieval in formalin-fixed, paraffin-embedded 
tissues: an enhancement method for immunohistochemical staining based on microwave oven 
heating of tissue sections.”  J Histochem Cytochem 1991 Mar; 39(6):471-478. 
 
Wagner, D. D., J. B. Olmsted, V. J. Marder.  “Immunolocalization of von Willebrand protein in 
Weibel-Palade bodies of human endothelial cells.”  J Cell Biology 1982 Oct; 95:355-360. 
 
Zanetta, L., S. G. Marcus, J. Vasile, M. Dobryansky, H. Cohen, K. Eng, P. Shamamian, P. 
Mignatti.  “Expression of von Willebrand Factor, an endothelial cell marker, is up-regulated by 
angiogenesis factors: a potential method for objective assessment of tumor angiogenesis.”  Int J 
Cancer 2000; 85:281-288. 
  
34 
 
 
 
 
 
 
 
 
 
 
Figures & Tables 
 
 
 
 
 
 
 
 
 
 
  
35 
 
 
  
Figure 1: Hamster with suspension apparatus.  Photo taken by New and Forsman, 2001. 
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Figure 3: Mouse ovarian tissue.  STS118P. 11/12/2010.  In 100X resolution. Figure 2: Mouse Muscle Tissue. 11/9/2010. In 100X resolution. 
Figure 4: Hamster Ovarian Tissue.  H16-RO-B. 11/12/2010. In 100X resoloution.  
Arrows show blood vessels with positive staining. 
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Figure 5: H14-LO-B.  2200 Day 1.  In 100X resolution.  11/19/2010.  1) Positive staining in the vascular endothelial 
cells.  2) A neighboring multilaminar follicle. 3&4) Excess staining in endothelial cells; potential new blood vessels. 
2 
1 
Figure 6: H17-RO-B.  Slide 1. 2200 Day 2.  11/15/2010.  In 100X resolution.  Arrows show multilaminar follicles.  
3 
4 
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Figure 7: H6-LO-B. 2200 Day 2. 11/21/10.  In 100X resolution.  1) Region of unilaminar follicles with no vasculature 
surrounding them.  2) a multilaminar follicle with surrounding vasculature.  This section was couterstained with 
hematoxylin.  The camera could not distinguish the color differentiation between hematoxylin and positive staining.   
Figure 8: H1-RO-B. slide 2. 1000 of Day 3. 11/23/2010. In 100X resolution. One of the 3 Corpora Lutea .  
Arrows show staining in the extensive vasculature within the CL’s. 
39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: H1-RO-B. slide 1. 1000 Day 3. 11/23/2010. In 100X Resolution. Small oval vessels stained positive for vWF 
surrounding a multilaminar follicle. 
Figure 10: H2-LO-A. 2200 Day 3. 11/23/2010. In 100X Resolution.  Small oval vessels stained positive for vWF. 
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                          Table 1: Data for Cage Control Hamster H14-LO-B.  2200 on Day 1. 
 
                      
                          Table 2: Data for Cage Control Hamster H17-RO-B. 2100 on Day 2. 
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                         Table 3: Data for Cage Control Hamster H11-RO-B. 1000 on Day 3. 
 
                    
                       Table 4: Data for Cage Control Hamster H13-RO-B. 2200 on Day 3. 
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                         Table 5: Data for Cage Control Hamster H19-RO-B. 2200 on Day 4. 
 
                    
                         Table 6: Data for Antiorthostatic Suspension Hamster H9-LO-B. 2200 on Day 1. 
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                         Table 7: Data for Antiorthostatic Suspension Hamster H6-LO-B. 2100 on Day 2. 
 
                    
                       Table 8: Data for Antiorthostatic Suspension Hamster H1-RO-B. 1000 on Day 3. 
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                     Table 9:  Data for Antiorthostatic Suspension for Hamster H2-LO-A.  2200 on Day 3. 
 
 
                  
                     Table 10: Data for Antiorthostatic Suspension Hamster H3-LO-A. 2200 on Day 4. 
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